Cleanroom Technology
  • Home
  • Categories
    • Pharmaceutical
    • Hi Tech Manufacturing
    • Food
    • Finance
    • Company News
    • Design & Build
    • Containment
    • Cleaning
    • Sustainability
    • HVAC
    • Personal Protection
    • Regulatory
  • CT CONFERENCE
  • Events
  • Directory
  • Search
    • Close search
  • Subscribe
  • Login
    • Password
      Password
      Forgot password? Close login form

Market Reports

Does cell therapy starting material collection require a cleanroom?

Does cell therapy starting material collection require a cleanroom?

R Marriott, K Land MD, and K Dosanjh JD from Vitalant explain common misconceptions when it comes to cell therapy contamination risk
An A-Z of biobased circular plastics

An A-Z of biobased circular plastics

Stefaan Vanhalle from STAXS explains the different types and their characteristics, along with considerations for special packaging requirements in cleanrooms
London Tech Week 2026: Drug discovery acceleration and speedy CFD analysis

London Tech Week 2026: Drug discovery acceleration and speedy CFD analysis

Technology leaders from across the world gathered for a week in London to make connections and educate attendees on recent developments
Standardising pharmaceutical sustainability: Speaking to the creators of BSI PAS 2090?

Standardising pharmaceutical sustainability: Speaking to the creators of BSI PAS 2090?

Courtney Soulsby, Sector Development Director at BSI, and Daniel Witte, Director of Corporate Sustainability at the standard’s co-sponsor and project management office, SLR Consulting, discuss their work standardising sustainability reporting and reduce “greenwashing”
What is RMM?

What is RMM?

RMM, or Rapid Microbial Methods, is a concept that is the future of cleanroom monitoring, but what is it and what technologies are out there?
What is happening with the cleanroom market in the United States?

What is happening with the cleanroom market in the United States?

Sophie Bullimore looks at some of the major trends and changes taking place in the US cleanroom market in the last year
Choosing a location to build  a data centre or fab

Choosing a location to build a data centre or fab

Katie Coulson from Skanska Advanced Technology discusses the process by which data centre and fab locations are chosen
Are centralised and de-centralised approaches to CGT manufacturing  really that different?

Are centralised and de-centralised approaches to CGT manufacturing really that different?

Andrew Scheffler from ScaleReady discusses whether CGT manufacturing should be centralised in large, industrial facilities, or decentralised closer to the patient in hospital-based or regional sites
Skanska's VP Kate Coulson on the company's technology division launch

Skanska's VP Kate Coulson on the company's technology division launch

The VP leading Skanska’s newly launched advanced technology division talks to Sophie Bullimore about the launch and the market landscape that has defined it
Cleanroom Technology Conference 2026: A review of the highlights

Cleanroom Technology Conference 2026: A review of the highlights

Attendees from Lonza, the NHS, ITH Pharma, Guardtech, AstraZeneca, Kingspan and more, have attended a two day event in Birmingham for the cleanroom and contamination control sector
When are isolators or RABS essential rather than optional?

When are isolators or RABS essential rather than optional?

The new EU GMP Annex 1 clearly stipulates that the absence of a barrier system must be thoroughly justified, but when is this, and what does it mean for isolator configuration, automation, glove handling, cleaning processes, and decontamination methods? Dr. Timo Krebsbach and Dipl.-Ing. Frank Lehmann from SKAN answer this and more
How to design your pharmaceutical facility disinfection programme: Development, validation, and implementation

How to design your pharmaceutical facility disinfection programme: Development, validation, and implementation

The development, validation, and implementation of a robust disinfection programme are critical components of Good Manufacturing Practices (GMP). James Polarine, Matt Hofacre and Tony Cundell explain what you need to do
Pharmaceutical waste: What do I do with it?

Pharmaceutical waste: What do I do with it?

Emma Cooke from Envirovue discusses the many hazardous elements of pharmaceutical waste and the importance of effective management and compliance
Pharma sector uses AI agents to reduce IT incident response times, says KTSL

Pharma sector uses AI agents to reduce IT incident response times, says KTSL

Aaron Perrott, CTO at KTSL, explains how pharmaceutical companies are using AI agents to improve IT response times, reduce MTTR and support faster clinical and operational workflows
Cleanroom compatibility of wafers: Practical guidance on selecting the right analysis methods

Cleanroom compatibility of wafers: Practical guidance on selecting the right analysis methods

Technical Account Manager Kalle Niiranen from Measurlabs reviews key techniques for confirming that wafer surfaces do not carry contaminants that could compromise cleanroom integrity
Advanced therapy production: A real-world business case for an open RABS upgrade in aseptic production

Advanced therapy production: A real-world business case for an open RABS upgrade in aseptic production

Thierry Bettinger, R&D Director from Bracco, explains the company’s rationale behind upgrading its Geneva pilot plant with an open Restricted Access Barrier System (RABS) ahead of BubbleGen product line launch
  • Previous
  • 1 (current)
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 28
  • Next

Trending Articles

  1. Walking the tightrope: a look at air change rates How can companies design their cleanrooms in order to reach the air change rates required by ISO? Words by Simplex's Jerry Cross
  2. Cleanrooms: What is the difference between clean-up period and recovery time? The implementation of the new Annex 1, and references to the ISO 14644 family of cleanroom standards have raised questions around the "Recovery time" and the "Clean-up period." Nataša Štirn from Klimer and ICCCS Chair Conor Murray discuss
  3. GMP Annex 1: Validation of disinfectants on cleanroom surfaces Published in August 2022, for implementation in August 2023, Karen Rossington from Contec looks at the revised version of EU GMP Annex 1 expanded and clarified the regulatory requirements of cleaning and disinfection in life science cleanrooms
  4. Virucidal testing of cleanroom disinfectants In “normal” times, with the exception of live vaccine manufacturers, control of viruses in cleanrooms is not usually the highest priority within contamination control. Viruses need a host to survive, as they are obligate parasites, just nucleic acid surrounded by a protein that can only replicate within a host cell, so their ability to survive on hard, dry surfaces is minimal. Contec’s Neil Simpson explains
  5. Incubating settle plates: Understanding growth patterns and when things are going wrong Steven Brimble from Cherwell Laboratories discusses why it is important to your environmental monitoring regime to understand growth characteristics of common cleanroom contaminants and how morphology shifts over time on various media

Upcoming event

CPhI South East Asia

08-10 July 2026 | Exhibition and Conference | Bangkok, Thailand
See all

Become a Subscriber

Cleanroom Technology keeps decision-makers worldwide updated on contamination control via digital, live, and print platforms. Our articles span the cleanroom lifecycle, from design to maintenance, including monitoring and compliance. Editors deliver breaking news, product launches, and innovations, and also commission exclusives on technical trends from industry experts

Subscribe now Already a subscriber? Sign in here. Find out more

Get our newsletter

Follow us

  • LinkedIn
  • About Cleanroom Technology
  • About HPCi Media
  • Newsletter sign up
  • Contact Us
  • Cleanroom Technology Event UK
  • Cleanroom Technology Event Singapore
  • Advertise
  • Terms and Conditions
  • Privacy
© HPCi Media Limited | Registered in England No. 06716035 | VAT GB 939828072 | a Claverley Group company Registered office address:
One Anchorage Avenue,
Shrewsbury Business Park,
Shrewsbury,
SY2 6FG, UK.